FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and ...

Arch Capital Group (ACGL) closed the latest trading day at $92.38, indicating a -0.09% change from the previous session's end. This change was narrower than the S&P 500's 2.24% loss on the day.

--Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Company’ s commercial product, AC5 ® Advanced Wound ...

SAWC Fall provides a venue to educate clinicians about AC5 Advanced Wound System, present case studies, and continue strategic meetings with wound care companies. FRAMINGHAM, Mass., Oct. 01, 2024 ...

SAWC Fall provides a venue to educate clinicians about AC5 Advanced Wound System, present case studies, and continue strategic meetings with wound care companies.FRAMINGHAM, Mass., Oct. 01, 2024 ...